Atrial Fibrillation
Conditions
Keywords
Telerehabilitation, Quality of life, Cardiac patients, Atrial fibrillation
Brief summary
This project has focus on patients with atrial fibrillation testing a telerehabilitation program for patients with atrial fibrillation.
Detailed description
The overall aim of the FP-AF program is to increase quality of life by giving the patients and relatives more knowledge about atrial fibrillation, its symptoms, and the issues of living with atrial fibrillation in everyday life. The specific aims are to individualize the rehabilitation process and help the patients and relatives develop their own self-management strategies using their own clinical data and their enhanced knowledge about AF.
Interventions
DEVICETelerehabilitation
Telerehabilitation platform: Hjerteportalen, blood pressure monitor (iHealth(neo/BP5s), weight scale (iHealth Lina), Activity tracker (FitBit inspire 3), ECG monitor (AliveCor KardiaMobile), sleep sensor (Emfit QS), video consultation (VDX by MedCom)
Sponsors
Department of Cardiology, Viborg Regional Hospital
Department of Cardiology, Silkeborg Regional Hospital
Center for Innovative Medical Technologies (CIMT), Odense University Hospital
Laboratory for Welfare Technology, Department of Health Science and Technology, Aalborg University
Aalborg University
Study design
Allocation
RANDOMIZED
Intervention model
PARALLEL
Primary purpose
TREATMENT
Masking
NONE
Intervention model description
Randomised controlled trial
Eligibility
Sex/Gender
ALL
Age
18 Years to No maximum
Healthy volunteers
No
Inclusion criteria
* Patients diagnosed with atrial fibrillation * Adults over 18 years * Living in Skive, Viborg or Silkeborg Municipalities * Living at home and capable of caring for themselves * Have basic computer skills or having a relative/friend with basic computer skills
Exclusion criteria
* Pregnancy * Refusal or inability to cooperate; or patient not does not speak, read or understand Danish * Life expectancy less than a year
Design outcomes
Primary
| Measure | Time frame | Description |
|---|---|---|
| Changes in AF specific health-related quality of life | For both intervention and control group: QoL will be measured at baseline, end of telerehabilitation (16 weeks) and after 28 weeks | The Atrial Fibrillation Effect on quality of life questionnaire (AFEQT) is a 20-item self-administered questionnaire designed to assess the impact of AF on the patients' health-related quality of life (HRQoL) across symptoms, daily activities, treatment concerns, and treatment satisfaction. Scores range from 0-100, with higher scores indicating better HRQoL |
Secondary
| Measure | Time frame | Description |
|---|---|---|
| Measurement of weight | Intervention group: Weight will be measured at baseline, twice a week, and as needed up to 16 weeks | Intervention group: Weight (Kilograms) |
| Measurement of bloodpressure | Intervention group: Bloodpressure will be measured at baseline, twice a week, and as needed up to 16 weeks | Intervention group: Bloodpressure (mmHG) (systolic and diastolic) |
| Measurement of pulse | Intervention group: Pulse will be measured at baseline, everyday, and as needed up to 16 weeks | Intervention group: Pulse (numbers per minute) |
| Measurement of steps | Intervention group: Steps will be measured from the date of randomization, everyday to end follow up (28 weeks) | Intervention group: numbers of steps taken |
| Measurement of sleep | Intervention group: Sleep will be measured every day up to 16 weeks | Intervention group: Sleep (numbers of hours per night) |
| Measurement of heart rhythm | Intervention group: ECG wil be measured at baseline, twice a week, and as needed up to 16 weeks | Intervention group: Electrocardiogram (ECG) |
| Changes in anxiety and depression | Both intervention and control group: At baseline, end of telerehabilitation (16 weeks) and after 28 weeks. | The patients degree of anxiety and depression measured by the Hospital Anxiety and Depression Scale (HADS). The patient will get a score between 0 and 21 for both depression and anxiety ( 0-7 points: low level of symptoms for depression or anxiety, 8-10 points: moderate level of symptoms for depression or anxiety, 11-21 points: high level of symptoms for depression or anxiety) |
| Changes in AF knowledge | For both intervention and control group: To be measured at baseline, end of telerehabilitation (16 weeks) and after 28 weeks | Changes in AF knowledge assessed by the Jessa Atrial Fibrillation Knowledge Questionnaire (JAKQ). JAKQ is a 16-item scale used to assess the knowledge the patients have about their illness. For every item, false responses or I do not know responses is scored as 0 and the correct responses are scored as 1. The total score of the scale is calculated by adding up the scores from each item. A score between 0% and 100% will be generated. 100% is the best possible score, meaning all questions was answered correctly. |
| Burden of AF | Both intervention and control group: At baseline, end of telerehabilitation (16 weeks) and after 28 weeks. | AF burden measured by the arrhythmia-specific questionnaire in Tachycardia and Arrhythmia (ASTA questionnaire). ASTA is used to assess symptoms and health-related quality of life(HRQoL) in patients with different forms of arrythmias, including AF. It is structured into three sections:Part I assesses demographic data such as the last episode of arrhythmia, current medication, and the presence of arrhythmia at the time of follow-up; Part II measures the arrhythmia-specific symptom burden; and part III assesses HRQoL. The ASTA 9-item symptom scale and the 13-item HRQoL scale utilize a four-point Likert-type scale, ranging from 'No' to 'Yes, a lot.' The total score ranges from 0 to 100, with a higher score indicating a greater symptom burden or a more negative impact on HRQoL. |
| Patients' and relatives' expectations for and experiences with participation in the tele-rehabilitation program (including the Heartportal) | Intervention group: Interviews at end of telerehabilitation (16 weeks) and logfiles and observation at end follow up (28 weeks) | Perspectives and experiences of patients and relatives participating in the FP-AF program (including the Heartportal) measured by interviews with patients and relatives. |
| Healthcare professionals' experiences with workflows and collaboration with each other in the telerehabilitation program. | Intervention group: End of telerehabilitation (16 weeks) | Perspectives and experiences of healthcare professionals participating in the FP-AF program through interviews. |
| Cost-effectiveness analysis of the FP-AF telerehabilitation program compared to conventional care | Both intervention and control group: at the end of telerehabilitation (16 weeks) | Cost-effectiveness analysis of the FP-AF telerehabilitation program compared to conventional care assessed by data from EPR and databases at Region Midt & Viborg, Skive and Silkeborg Municipalities. |
| Patterns in multiparametric clinical monitoring | Intervention group: At the end of telerehabilitation (16 weeks). | Data from devices for measuring blood pressure (mmHG) (systolic and diastolic) to analyze and identify correlations in multiparametric data. |
| Future governance and infrastructure for telerehabilitation of AF patients | Intervention group: At the end of telerehabilitation (16 weeks) | Interviews with patients and stakeholders |
| Changes in motivation | Both intervention and control group: At baseline, end of telerehabilitation (16 weeks) and after 28 weeks. | Changes in motivation measured by Healthcare, Self-Determination Theory Questionnaire Packet (HC-SDTQ) comprised of Treatment Self-Regulation Questionnaire (TSRQ); Perceived Competence Scale (PCS); and Health Care Climate Questionnaire (HCCQ). TSRQ is used to assess different forms of motivation within the self determination theory (STD). The patients are asked to answer 15 questions regarding why they either follow or do not follow their treatment by marking to which degree each reason is true on a scale form 1 to 7, with 7 being very true. |
Countries
Denmark
Contacts
Primary ContactBirthe Dinesen, MSc, Ph.D
Backup ContactDorthe Svenstrup, MD, Ph.D
Outcome results
None listed